Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efficacy of Dextromethorphan”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableUnknownNCT01553435
What this trial is testing

Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients

Who this might be right for
PainOpioid ToleranceAnalgesia Tolerance
King Abdullah International Medical Research Center 36
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Post-approval studies (Phase 4)Looking for participantsNCT06223880
What this trial is testing

Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Who this might be right for
Major Depressive Disorder
Axsome Therapeutics, Inc. 350
Large-scale testing (Phase 3)Looking for participantsNCT07766655
What this trial is testing

Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

Who this might be right for
Smoking Cessation
Axsome Therapeutics, Inc. 705
Large-scale testing (Phase 3)Study completedNCT04039022
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant DepressionDepression
Axsome Therapeutics, Inc. 876
Post-approval studies (Phase 4)Ended earlyNCT01257542
What this trial is testing

Acute Cough Study In Children

Who this might be right for
Common ColdInfections, Upper Respiratory Tract
Pfizer 140
Large-scale testing (Phase 3)Study completedNCT00021697
What this trial is testing

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Avanir Pharmaceuticals 100
Post-approval studies (Phase 4)Ended earlyNCT02651116
What this trial is testing

Dextromethorphan Pediatric Acute Cough Study

Who this might be right for
Cough
Pfizer 131
Testing effectiveness (Phase 2)Study completedNCT01767129
What this trial is testing

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Who this might be right for
DyskinesiaParkinson's Disease
Avanir Pharmaceuticals 14
Testing effectiveness (Phase 2)Ended earlyNCT04634669
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 181
Large-scale testing (Phase 3)UnknownNCT04687566
What this trial is testing

Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction

Who this might be right for
Amphetamine AddictionPharmacotherapy
National Cheng-Kung University Hospital 120
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Large-scale testing (Phase 3)Study completedNCT00113620
What this trial is testing

Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy

Who this might be right for
PainDiabetic Neuropathy
Avanir Pharmaceuticals 450
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Post-approval studies (Phase 4)Study completedNCT01799941
What this trial is testing

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)

Who this might be right for
Pseudobulbar Affect (PBA)StrokeDementia+1 more
Avanir Pharmaceuticals 367
Large-scale testing (Phase 3)Study completedNCT00573443
What this trial is testing

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Who this might be right for
Pseudobulbar Affect (PBA)
Avanir Pharmaceuticals 326
Large-scale testing (Phase 3)Study completedNCT01189006
What this trial is testing

Add-On Therapy to Risperidonein Schizophrenia

Who this might be right for
Schizophrenia
National Cheng-Kung University Hospital 161
Large-scale testing (Phase 3)Ended earlyNCT02446132
What this trial is testing

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,197
Testing effectiveness (Phase 2)Study completedNCT02153502
What this trial is testing

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Depressive Disorder, Treatment-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 206
Next Page